Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

Varespladib (LY315920) and Methyl Varespladib (LY333013) Abrogate or Delay Lethality Induced by Presynaptically Acting Neurotoxic Snake Venoms

Open access
Gutiérrez, José María, Lewin, Matthew R., Williams, David. J., Lomonte, Bruno · 2020 · Toxins

Abstract

The phospholipase A2 (PLA2) inhibitor Varespladib (LY315920) and its orally bioavailable prodrug, methyl-Varespladib (LY333013) inhibit PLA2 activity of a wide variety of snake venoms. In this study, the ability of these two forms of Varespladib to halt or delay lethality of potent neurotoxic snake venoms was tested in a mouse model. The venoms of Notechis scutatus, Crotalus durissus terrificus, Bungarus multicinctus, and Oxyuranus scutellatus, all of which have potent presynaptically acting neurotoxic PLA2s of variable quaternary structure, were used to evaluate simple dosing regimens. A supralethal dose of each venom was injected subcutaneously in mice, followed by the bolus intravenous (LY315920) or oral (LY333013) administration of the inhibitors, immediately and at various time intervals after envenoming. Control mice receiving venom alone died within 3 h of envenoming. Mice injected with O. scutellatus venom and treated with LY315920 or LY333013 survived the 24 h observation period, whereas those receiving C. d. terrificus and B. multicinctus venoms survived at 3 h or 6 h with a single dose of either form of Varespladib, but not at 24 h. In contrast, mice receiving N. scutatus venom and then the inhibitors died within 3 h, similarly to the control animals injected with venom alone. LY315920 was able to reverse the severe paralytic manifestations in mice injected with venoms of O. scutellatus, B. multicinctus, and C. d. terrificus. Overall, results suggest that the two forms of Varespladib are effective in abrogating, or delaying, neurotoxic manifestations induced by some venoms whose neurotoxicity is mainly dependent on presynaptically acting PLA2s. LY315920 is able to reverse paralytic manifestations in severely envenomed mice, but further work is needed to understand the significance of species-specific differences in animal models as they compare to clinical syndromes in human and for potential use in veterinary medicine.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/toxins12020131

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Reversion of paralytic manifestations in groups of four mice receiving three LD50s of Crotalus d. terrificus venom by the subcutaneous route. A single bolus dose of LY315920 (10 mg/kg i.v.) (VAR) was administered at the time indicated by the red arrow, when mice showed paralytic manifestations corresponding to a severity score of 3. Paralysis was reversed for the following 3 h and returned afterwards.
Figure 1 Reversion of paralytic manifestations in groups of four mice receiving three LD50s of Crotalus d. terrificus venom by the subcutaneous route. A single bolus dose of LY315920 (10 mg/kg i.v.) (VAR) was administered at the time indicated by the red arrow, when mice showed paralytic manifestations corresponding to a severity score of 3. Paralysis was reversed for the following 3 h and returned afterwards.CC BY · PubMed Central
Figure 2 Reversion of paralytic manifestations in groups of four mice receiving three LD50s of Bungarus multicinctus venom. A single bolus dose of LY315920 (10 mg/kg i.v.) (VAR) was administered at the time indicated by the red arrow, when mice showed paralytic manifestations corresponding to a severity score of 2. Paralysis was completely reversed for the following 6 h.
Figure 2 Reversion of paralytic manifestations in groups of four mice receiving three LD50s of Bungarus multicinctus venom. A single bolus dose of LY315920 (10 mg/kg i.v.) (VAR) was administered at the time indicated by the red arrow, when mice showed paralytic manifestations corresponding to a severity score of 2. Paralysis was completely reversed for the following 6 h.CC BY · PubMed Central
Figure 3 Reversion of paralytic manifestations in groups of four mice receiving 12 LD50s of Oxyuranus scutellatus venom by the subcutaneous route. A single bolus dose of LY315920 (10 mg/kg i.v.) (VAR) was administered at the time indicated by the red arrow, when mice showed paralytic manifestations corresponding to a severity score of 2. Paralysis was completely reversed for the following 5 h.
Figure 3 Reversion of paralytic manifestations in groups of four mice receiving 12 LD50s of Oxyuranus scutellatus venom by the subcutaneous route. A single bolus dose of LY315920 (10 mg/kg i.v.) (VAR) was administered at the time indicated by the red arrow, when mice showed paralytic manifestations corresponding to a severity score of 2. Paralysis was completely reversed for the following 5 h.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 38 references

Research works printed but not linked: 2

  1. Fry, B.G. (2015). Group I phospholipase A2 enzymes. Venomous Reptiles and Their Toxins. Evolution, Pathophysiology & Biodiscovery, Oxford University Press.
  2. Finney, D.J. (1971). Probit Analysis, Cambridge University Press.

Cited by

See all 95

Metadata

Authors
Gutiérrez, J. M., Lewin, M. R., Williams, D. J., & Lomonte, B.
Affiliations
  • Instituto Clodomiro Picado, Facultad de Microbiología, Universidad de Costa Rica, San José 11501-2060, Costa Rica
  • California Academy of Sciences (US)
  • Global Snakebite Initiative, Ashgrove Qld 4060, Australia
  • Universidad de Costa Rica (CR)
Venue
Toxins
Publisher
MDPI AG
Published
2020-02-20
Volume
12
Issue
2
Pages
131
ISSN
2072-6651 (ISSN-L)
OpenAlex
W3009813414
Cited by
92
References
38
Citations by year
2026: 11 · 2025: 7 · 2024: 11 · 2023: 14 · 2022: 16 · 2021: 20 · 2020: 13
FWCI
9.24
Type
journal article
Language
en
Open access
Locations
  • Toxins (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (publishedVersion, other-oa)
  • Investigative News in Education (Universidad de Costa Rica) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Vicerrectoría de Investigación, Universidad de Costa Rica (No grant number)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Venomous Animal Envenomation and Studies
  • Health Sciences › Medicine › Emergency Medicine › Poisoning and overdose treatments
  • Life Sciences › Agricultural and Biological Sciences › Ecology, Evolution, Behavior and Systematics › Amphibian and Reptile Biology
Keywords
varespladib, phospholipase A2 inhibitors, snake venom neurotoxins, envenomation, Oxyuranus scutellatus, Crotalus durissus terrificus, Bungarus multicinctus, Notechis scutatus, antivenom therapy, prodrugs
MeSH terms
Acetates, Animals, Disease Models, Animal, Dose-Response Relationship, Drug, Indoles, Keto Acids, Lethal Dose 50, Snake Bites, Snake Venoms, Time Factors, Survival Analysis, Neurotoxicity Syndromes, Mice, Phospholipases A2, Phospholipase A2 Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Varespladib (LY315920) and Methyl Varespladib (LY333013) Abrogate or Delay Lethality Induced by Presynaptically Acting Neurotoxic Snake Venoms. https://app.cochat.ai/papers/10.3390/toxins12020131
The paper
Gutiérrez, J. M., Lewin, M. R., Williams, D. J., & Lomonte, B. (2020). Varespladib (LY315920) and Methyl Varespladib (LY333013) Abrogate or Delay Lethality Induced by Presynaptically Acting Neurotoxic Snake Venoms. Toxins. https://doi.org/10.3390/toxins12020131

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.